Hereditary Pancreatic Cancer

Pancreatology

Volumn 1, Issue 5, 2001, Pages 466-471

  Lynch, Henry T ^a   Brand, Randall E ^b   Deters, Carolyn A ^a   Shaw, Trudy G ^a   Lynch, Jane F ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

Author keywords

CDKN2A; Familial atypical multiple mole melanoma syndrome; Familial cancer; Hereditary cancer; Pancreatic cancer

Indexed keywords

BIOLOGICAL MARKER;

GENETICS; HUMAN; MUTATION; PANCREAS TUMOR; PANCREATITIS; REGISTER; REVIEW;

BIOLOGICAL MARKERS; HUMANS; MUTATION; PANCREATIC NEOPLASMS; PANCREATITIS; REGISTRIES;

EID: 0035552204     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000055849     Document Type: Article

References (50)

1. Greenlee RT, Hill-Harmon MB, Murray T, et al: Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
2. Cubilla AL, Fortner J, Fitzgerald PJ: Lymph node involvement in carcinoma of the head of the pancreas. Cancer 1978;41:880-887.
3. Schenk M, Schwartz AG, O'Neal E, et al: Familial risk of pancreatic cancer. J Natl Cancer Inst 2001;93:640-644.
4. Lowenfels AB, Maisonneuve P, Whitcomb DC, et al: Risk factors for cancer in hereditary pancreatitis. Med Clin North Am 2000;84:565-573.
5. Brand RE, Lynch HT: Hereditary pancreatic adenocarcinoma: A clinical perspective. Med Clin North Am 2000;84:665-675.
6. Falk RT, Pickle LW, Fontham ET, et al: Lifestyle risk factors for pancreatic cancer in Louisiana: A case-control study. Am J Epidemiol 1988;128:324-336.
7. Ghadirian P, Boyle P, Simard A, et al: Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol 1991;10:183-196.
8. Kip1 protein levels independently predict outcome after breast cancer. J Clin Oncol 2000;18: 4045-4052.
9. Lynch HT, Smyrk T, Kern SE, et al: Familial pancreatic cancer: A review. Semin Oncol 1996;23:251-275.
10. Fitzgibbons RJ Jr, Lynch HT, Stanislav GV, et al: Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II). Ann Surg 1987;206:289-295.
11. Lynch HT, Fitzsimmons ML, Smyrk TC, et al: Familial pancreatic cancer: Clinicopathologic study of 18 nuclear families. Am J Gastroentcrol 1990;85:54-60.
12. Lynch HT, Follett K, Shonka M, et al: Familial colon cancer in two high risk Nebraska counties; in: Proceedings of the AACR/ASCO Annual Meeting. Baltimore, Williams & Wilkins, 1980.
13. Lynch HT, Voorhees GJ, Lanspa SJ, et al: Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: A family study. Br J Cancer 1985;52:271-273.
14. Brentnall TA, Bronner MP, Byrd DR, et al: Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 1999;131: 247-255.
15. Goggins M, Schutte M, Lu J, et al: Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 1996;56:5360-5364.
16. Lowenfels AB, Maisonneuve P, DiMagno EP, et al: Hereditary pancreatitis and the risk of pancreatic cancer. J Natl Cancer Inst 1997;89: 442-446.
17. Gorry MC, Gabbaizedeh D, Furey W, et al: Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology 1997;113: 1063-1068.
18. Whitcomb DC, Gorry MC, Preston RA, et al: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14:141-145.
19. Giardiello FM, Welsh SB, Hamilton SR, et al: Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 1987;316:1511-1514.
20. Su GH, Hruban RH, Bova GS, et al: Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol 1999;154:1835-1840.
21. Bergman W, Watson P, de Jong J, et al: Systemic cancer and the FAMMM syndrome. Br J Cancer 1990;61:932-936.
22. Lynch HT, Frichot BC, Lynch P, et al: Family studies of malignant melanoma and associated cancer. Surg Gynecol Obstet 1975;141:517-522.
23. Bullock GJ, Green JL, Baron PL: Impact of p16 expression on surgical management of malignant melanoma and pancreatic carcinoma. Am J Surg 1999;177:15-18.
24. Lal G, Liu G, Schmocker B, et al: Inherited predisposition to pancreatic adenocarcinoma: Role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res 2000;60:409-416.
25. Moskaluk CA, Hruban RH, Kern SE: p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1997;57:2140-2143.
26. INK4 allele (Asp145Cys) in a family with multiple pancreatic carcinomas (abstract). Hum Mutat 1997;12:70.
27. Schutte M, Hruban RH, Geradts J, et al: Abrogation of the Rb/p16 tumor suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 1997;57:3126-3130.
28. Vasen HFA, Gruis NA, Frants RR, et al: Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer 2000;87:809-811.
29. Vasen HFA, Watson P, Mecklin J-P, et al: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999; 116:1453-1456.
30. Hruban RH, Petersen GM, Ha PK, et al: Genetics of pancreatic cancer: From genes to families. Surg Oncol Clin N Am 1998;7:1-23.
31. Castleman B: Case 25, case records of the Massachusetts General Hospital. N Engl J Med 1972;286:1353-1359.
32. Lynch HT, Fusaro RM, Kimberling WJ, et al: Familial atypical multiple mole-melanoma (FAMMM) syndrome: Segregation analysis. J Med Genet 1983;20:342-344.
33. INK4 mutations. N Engl J Med 1995;333:970-974.
34. Caldas C, Hahn SA, da Costa LT, et al: Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 1994;8:27-32.
35. Schenk M, Severson RK, Pawlish KS: The risk of subsequent primary carcinoma of the pancreas in patients with cutaneous malignant melanoma. Cancer 1998;82:1672-1676.
36. Hashemi J, Platz A, Ueno T, et al: CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas. Cancer Res 2000; 60:6864-6867.
37. Hruban RH, Goggins M, Parsons J, et al: Progression model for pancreatic cancer. Clin Cancer Res 2000;6:2969-2972.
38. Vogelstein B, Fearon ER, Hamilton SR, et al: Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-532.
39. Almoguerra C, Shibata D, Forrester K, et al: Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988; 53:549-554.
40. Cubilla AL, Fitzgerald PJ: Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res 1976;36:2690-2698.
41. Hahn SA, Schmiegel WH: Recent discoveries in cancer genetics of exocrine pancreatic neoplasia. Digestion 1998;59:493-501.
42. Brat DJ, Lillemoe KD, Yeo CJ, et al: Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol 1998;22:163-169.
43. Brockie E, Anand A, Albores-Saavedra J: Progression of atypical ductal hyperplasia/carcinoma in situ of the pancreas to invasive adenocarcinoma. Ann Diagn Pathol 1998;2:286-292.
44. Cameron JL, Crist DW, Sitzmann JV, et al: Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991;161:120-125.
45. Moosa AR, Gamagami RA: Diagnosis and staging of pancreatic neoplasms. Surg Clin North Am 1995;75:871-890.
46. Trede M: The surgical treatment of pancreatic carcinoma. Surgery 1985;97:28-35.
47. Ariyama J, Suyama M, Satoh K, et al: Imaging of small pancreatic ductal adenocarcinoma. Pancreas 1998;16:396-401.
48. Bhutani MS: Endoscopic ultrasonography: Changes of chronic pancreatitis in asymptomatic and symptomatic alcoholic patients. J Ultrasound Med 1999;18:455-462.
49. Watanabe H, Yamaguchi Y, Ha A, et al: Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay. Pancreas 1998;17:341-347.
50. Steinberg W: The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol 1990;85:350-355.